Pacer Advisors
HRMY icon

Pacer Advisors’s Harmony Biosciences HRMY Stock Holding History

Pacer Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.7M Buy
348,239
+29,712
+9% +$937K 0.03% 442
2026
Q1 		$8.92M Buy
318,527
+28,174
+10% +$924K 0.03% 467
2025
Q4 		$10.9M Sell
290,353
-72,595
-20% -$2.39M 0.03% 475
2025
Q3 		$10M Sell
362,948
-17,207
-5% -$593K 0.03% 478
2025
Q2 		$12M Sell
380,155
-116,804
-24% -$3.76M 0.03% 436
2025
Q1 		$16.5M Sell
496,959
-1,782,959
-78% -$63.9M 0.04% 347
2024
Q4 		$78.5M Buy
2,279,918
+351,582
+18% +$12.1M 0.17% 142
2024
Q3 		$77.1M Sell
1,928,336
-581,273
-23% -$20.4M 0.16% 155
2024
Q2 		$75.7M Buy
2,509,609
+14,695
+0.6% +$442K 0.17% 151
2024
Q1 		$83.8M Buy
2,494,914
+1,270,004
+104% +$40.8M 0.19% 134
2023
Q4 		$39.6M Buy
1,224,910
+1,224,681
+534,795% +$34.2M 0.11% 202
2023
Q3 		$7.5K Sell
229
-436,476
-100% -$15.2M ﹤0.01% 2581
2023
Q2 		$15.4M Buy
+436,705
New +$15.1M 0.06% 281

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pacer Advisors's HRMY Position: Q2 2026 in Review

Pacer Advisors increased its Harmony Biosciences (HRMY) stake by 9.3% in Q2 2026, buying an estimated $937K and bringing the position to 348,239 shares worth $12.7M. The position accounts for 0.03% of the portfolio, ranked #442.

Pacer Advisors first reported a position in HRMY in Q2 2023 and has held it in 13 quarters since. The position peaked at $83.8M in Q1 2024. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Pacer Advisors held 348,239 shares of Harmony Biosciences worth $12.7M as of Q2 2026.
  • Pacer Advisors bought 29,712 Harmony Biosciences shares in Q2 2026, an estimated $937K.
  • Harmony Biosciences made up 0.03% of Pacer Advisors's portfolio in Q2 2026, its #442 holding.
  • Pacer Advisors first reported a position in Harmony Biosciences in Q2 2023 and has held it in 13 quarters since.
  • Pacer Advisors's Harmony Biosciences position peaked at $83.8M in Q1 2024.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.